Fortress Biotech, Inc. financial data

Symbol
FBIO, FBIOP on Nasdaq
Location
Bay Harbor Islands, FL
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 174% % 31%
Quick Ratio 20% % 51%
Debt-to-equity 366% % -51%
Return On Equity 12% % -98%
Return On Assets 2.4% %
Operating Margin -191% % -14%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 31,005,170 shares 12%
Entity Public Float $30,782,670 USD -42%
Common Stock, Value, Issued $31,000 USD 11%
Weighted Average Number of Shares Outstanding, Basic 27,244,474 shares 38%
Weighted Average Number of Shares Outstanding, Diluted 33,100,961 shares 68%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $17,631,000 USD 21%
Research and Development Expense $61,031,000 USD -52%
Costs and Expenses $151,834,000 USD -9.9%
Operating Income (Loss) $89,531,000 USD 16%
Nonoperating Income (Expense) $35,968,000 USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $8,853,000 USD
Income Tax Expense (Benefit) $269,000 USD -40%
Net Income (Loss) Attributable to Parent $3,987,000 USD
Earnings Per Share, Basic -0.01 USD/shares 100%
Earnings Per Share, Diluted -0.08 USD/shares 99%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $86,218,000 USD 46%
Accounts Receivable, after Allowance for Credit Loss, Current $17,983,000 USD 69%
Inventory, Net $11,818,000 USD 0.25%
Assets, Current $118,503,000 USD 37%
Property, Plant and Equipment, Net $2,611,000 USD -23%
Operating Lease, Right-of-Use Asset $12,321,000 USD -13%
Other Assets, Noncurrent $18,082,000 USD 441%
Assets $181,407,000 USD 43%
Accounts Payable, Current $18,771,000 USD -45%
Accrued Liabilities, Current $45,171,000 USD -30%
Liabilities, Current $54,067,000 USD -23%
Operating Lease, Liability, Noncurrent $12,765,000 USD -17%
Other Liabilities, Noncurrent $1,616,000 USD -7.8%
Liabilities $116,222,000 USD -17%
Retained Earnings (Accumulated Deficit) $730,115,000 USD 0.54%
Stockholders' Equity Attributable to Parent $55,862,000 USD 164%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $65,185,000 USD
Liabilities and Equity $181,407,000 USD 43%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $19,563,000 USD 23%
Net Cash Provided by (Used in) Financing Activities $52,142,000 USD 87%
Net Cash Provided by (Used in) Investing Activities $1,165,000 USD
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 31,005,170 shares 12%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $33,744,000 USD 1265%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $87,438,000 USD 44%
Interest Paid, Excluding Capitalized Interest, Operating Activities $3,324,000 USD 100%
Deferred Tax Assets, Valuation Allowance $377,965,000 USD 3.2%
Deferred Tax Assets, Gross $384,624,000 USD 2.9%
Operating Lease, Liability $14,894,000 USD -16%
Depreciation $489,000 USD -54%
Lessee, Operating Lease, Liability, to be Paid $17,874,000 USD -18%
Property, Plant and Equipment, Gross $7,663,000 USD -50%
Operating Lease, Liability, Current $2,129,000 USD -15%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,940,000 USD -10%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,937,000 USD -17%
Operating Lease, Weighted Average Discount Rate, Percent 0.061 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2,980,000 USD -24%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,967,000 USD 1.5%
Deferred Tax Assets, Operating Loss Carryforwards $232,740,000 USD 10%
Preferred Stock, Shares Issued 3,427,138 shares 0%
Preferred Stock, Shares Authorized 15,000,000 shares 0%
Unrecognized Tax Benefits $3,200,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $3,011,000 USD 1.5%
Operating Lease, Payments $852,000 USD -7.4%
Additional Paid in Capital $785,943,000 USD 4.1%
Preferred Stock, Shares Outstanding 3,427,138 shares 0%
Amortization of Intangible Assets $4,175,000 USD 31%
Deferred Tax Assets, Net of Valuation Allowance $6,659,000 USD -11%
Share-based Payment Arrangement, Expense $42,470,000 USD 111%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%